Medication info
Pavis Rabeprazole 10 mg (Rabeprazole Sodium)

Pavis Rabeprazole 10 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
Korea Pavis Pharmaceutical Co., Ltd.
Appearance
Pale yellow round enteric-coated tablet
Packaging
Domestic use - 28 tablets/box [14 tablets/AluAlu*2]
Approval status
Active

MFDS item code 201805144 · Approved 2018.12.18 · Insurance code 621803310

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (in combination for eradication), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer : The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease : Administer 10 mg or 20 mg once daily for 4–8 weeks. If the condition is not resolved after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease : Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled with on-demand treatment using 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease : Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication : Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended to administer this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome : The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the needs of each patient. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. ◯ Patients with hepatic impairment Hepatic encephalopathy has been reported as an adverse reaction in patients with cirrhosis. Therefore, administer with caution. ◯ Older adults Hepatic function is often reduced; therefore, administer with caution.
Child dose
◯ Children Safety has not been established in children.

Ingredients

Manufacturer
Korea Pavis Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (in combination for eradication), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medicine alleviates symptoms of ulcers occurring in the stomach or duodenum and is used for long-term treatment of gastroesophageal reflux disease. It can also be used in combination with antibiotics for patients with gastrointestinal ulcers due to Helicobacter pylori infection. It is effective for rare diseases such as Zollinger-Ellison syndrome. Through these effects, it helps improve gastrointestinal-related conditions.

How to take

Adult dose

Gastric ulcer, duodenal ulcer : The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease : Administer 10 mg or 20 mg once daily for 4–8 weeks. If the condition is not resolved after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease : Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled with on-demand treatment using 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease : Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication : Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended to administer this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome : The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the needs of each patient. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. ◯ Patients with hepatic impairment Hepatic encephalopathy has been reported as an adverse reaction in patients with cirrhosis. Therefore, administer with caution. ◯ Older adults Hepatic function is often reduced; therefore, administer with caution.

Child dose

◯ Children Safety has not been established in children.

Precautions

This medicine should not be administered to patients with certain allergic reactions or those who have hypersensitivity when combined with certain antibiotics. Women who are pregnant or nursing should not take this medication. Caution should be taken when prescribing to patients with impaired liver function or older adults, as well as in those with a history of drug allergies. If allergic symptoms such as skin rash, itching, or urticaria occur during treatment, discontinue use immediately. Regular blood tests and liver function tests should be conducted, and if abnormalities are found, the medication should be stopped, and appropriate action should be taken. Various side effects may occur in different body systems including cardiovascular, gastrointestinal, and nervous systems; consult healthcare providers if symptoms arise. Long-term use may increase the risk of fractures, necessitating caution during extended treatments. As this medication inhibits gastric acid secretion, the risk of intestinal bacterial infections may slightly increase; report persistent diarrhea to healthcare providers. Caution is advised during driving or machine operation due to potential drowsiness. There may be interactions with other medications, so patients should inform their healthcare provider of any other medications they are taking, especially when combined with antibiotics or antivirals. This medication should be swallowed whole without chewing or crushing, and must be kept out of reach of children. It should not be taken during pregnancy due to unproven safety, and it is preferable to avoid use while nursing.

Side effects

Rash, urticaria, itching, erythrocyte reduction, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechial hemorrhage, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, ALT elevation, AST elevation, ALP elevation, γ-GTP elevation, LDH elevation, total bilirubin elevation, fulminant hepatitis, hepatic dysfunction, jaundice, hypertension, myocardial infarction, abnormal ECG, migraine, syncope, angina, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QT prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal bloating, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastritis, stomatitis, taste disturbance, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, volume overload, limb weakness, sensory loss, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, respiratory distress, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, pneumonitis, myalgia, back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, muscle stiffness, neuralgia, single contraction, sweating, alopecia, skin dryness, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, urinary difficulties, kidney stones, uterine bleeding, polyuria, gynecomastia, increased total cholesterol, increased triglycerides, increased BUN, increased serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, loss of appetite, neck stiffness, photosensitivity reaction, hangover effect, weight loss, gout, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, anaphylaxis, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reactions, myalgia, arthralgia, interstitial nephritis, gynecomastia, increased thyroid-stimulating hormone, erythema multiforme, toxic epidermal necrolysis, mucous membrane syndrome, increased INR, prolonged prothrombin time, bone fractures, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, skin lupus.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is best to store the medication at room temperature between 1 °C and 30 °C. Keep it safe from extreme heat or cold.

Appearance and packaging

Appearance

Pale yellow round enteric-coated tablet

Package unit

Domestic use - 28 tablets/box [14 tablets/AluAlu*2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.